1. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875-91. Epub 2008/09/25. doi: 10.1182/blood-2008-04-150250. PubMed PMID: 18812465.
2. Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lübbert M, Hänel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Döhner K, Sauer M, Ganser A, Amadori S, Mandelli F, Döhner H, Ehninger G, Schlenk RF, Platzbecker U. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111-21. Epub 2013/07/12. doi: 10.1056/NEJMoa1300874. PubMed PMID: 23841729.
3. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M, Howe K, Dastugue N, Jansen J, Radford-Weiss I, Lo Coco F, Lessard M, Hernandez JM, Delabesse E, Head D, Liso V, Sainty D, Flandrin G, Solomon E, Birg F, Lafage- Pochitaloff M. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". Blood. 2000;96(4):1297-308. Epub 2000/08/15. PubMed PMID: 10942371.
4. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood. 1996;87(3):882-6. Epub 1996/02/01. PubMed PMID: 8562957.
5. Wells RA, Catzavelos C, Kamel-Reid S. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet. 1997;17(1):109-13. Epub 1997/09/01. doi: 10.1038/ng0997-109. PubMed PMID: 9288109.
6. Arnould C, Philippe C, Bourdon V, Gr goire MJ, Berger R, Jonveaux P. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Hum Mol Genet. 1999;8(9):1741-9. Epub 1999/08/11. doi: 10.1093/hmg/8.9.1741. PubMed PMID: 10441338.
7. Liu M, Zhao X, Pan W, Qian Z, Du M, Wang LM, Huang H, Xiao H. A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy. Br J Haematol. 2021. Epub 2021/07/14. doi: 10.1111/bjh.17642. PubMed PMID: 34254314.
8. Osumi T, Tsujimoto SI, Tamura M, Uchiyama M, Nakabayashi K, Okamura K, Yoshida M, Tomizawa D, Watanabe A, Takahashi H, Hori T, Yamamoto S, Hamamoto K, Migita M, Ogata-Kawata H, Uchiyama T, Kizawa H, Ueno-Yokohata H, Shirai R, Seki M, Ohki K, Takita J, Inukai T, Ogawa S, Kitamura T, Matsumoto K, Hata K, Kiyokawa N, Goyama S, Kato M. Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. Cancer Res. 2018;78(16):4452-8. Epub 2018/06/21. doi: 10.1158/0008-5472.CAN-18-0840. PubMed PMID: 29921692.
9. Zhao J, Liang JW, Xue HL, Shen SH, Chen J, Tang YJ, Yu LS, Liang HH, Gu LJ, Tang JY, Li BS. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia. Leukemia. 2019;33(6):1387-99. Epub 2018/12/24. doi: 10.1038/s41375-018-0338-z. PubMed PMID: 30575821.
10. Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 2016;30(3):728-39. Epub 2015/10/10. doi: 10.1038/leu.2015.275. PubMed PMID: 26449661; PubMed Central PMCID: PMCPMC4775400.
11. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-50. Epub 2005/10/04. doi: 10.1073/pnas.0506580102. PubMed PMID: 16199517; PubMed Central PMCID: PMCPMC1239896.
12. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, Shurtleff SA, Pounds S, Cheng C, Ma J, Ribeiro RC, Rubnitz JE, Girtman K, Williams WK, Raimondi SC, Liang DC, Shih LY, Pui CH, Downing JR. Gene expression profiling of pediatric acute myelogenous leukemia. Blood. 2004;104(12):3679-87. Epub 2004/07/01. doi: 10.1182/blood-2004-03-1154. PubMed PMID: 15226186.
13. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature. 1998;391(6669):815-8. Epub 1998/03/05. doi: 10.1038/35901. PubMed PMID: 9486655.
14. Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF- RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood. 1998;91(8):2634-42. Epub 1998/05/16. PubMed PMID: 9531570.
15. Hauksdottir H, Farboud B, Privalsky ML. Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand. Mol Endocrinol. 2003;17(3):373-85. Epub 2003/01/30. doi: 10.1210/me.2002-0340. PubMed PMID: 12554770.
16. Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res. 2001;61(1):2-7. Epub 2001/02/24. PubMed PMID: 11196162.
17. Lehmann S, Paul C, Törmä H. The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity. Leuk Lymphoma. 2002;43(4):851-8. Epub 2002/08/03. doi: 10.1080/10428190290016999. PubMed PMID: 12153175.
18. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S, Pelicci PG. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 2002;295(5557):1079-82. Epub 2002/02/09. doi: 10.1126/science.1065173. PubMed PMID: 11834837.
19. König J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, Turner DJ, Luscombe NM, Ule J. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol. 2010;17(7):909-15. Epub 2010/07/06. doi: 10.1038/nsmb.1838. PubMed PMID: 20601959; PubMed Central PMCID: PMCPMC3000544.
20. Zarnack K, König J, Tajnik M, Martincorena I, Eustermann S, Stévant I, Reyes A, Anders S, Luscombe NM, Ule J. Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of Alu elements. Cell. 2013;152(3):453-66. Epub 2013/02/05. doi: 10.1016/j.cell.2012.12.023. PubMed PMID: 23374342; PubMed Central PMCID: PMCPMC3629564.
21. McCloskey A, Taniguchi I, Shinmyozu K, Ohno M. hnRNP C tetramer measures RNA length to classify RNA polymerase II transcripts for export. Science. 2012;335(6076):1643-6. Epub 2012/03/31. doi: 10.1126/science.1218469. PubMed PMID: 22461616.
22. Su Z, Liu X, Xu Y, Hu W, Zhao C, Zhao H, Feng X, Zhang S, Yang J, Shi X, Peng J. Novel reciprocal fusion genes involving HNRNPC and RARG in acute promyelocytic leukemia lacking RARA rearrangement. Haematologica. 2020;105(7):e376-e8. Epub 2020/05/02. doi: 10.3324/haematol.2019.244715. PubMed PMID: 32354871; PubMed Central PMCID: PMCPMC7327640.
23. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835-9. Epub 1995/12/15. doi: 10.1016/0092-8674(95)90199-x. PubMed PMID: 8521507; PubMed Central PMCID: PMCPMC6159888.
24. Tan MH. Current treatment of insulin resistance in type 2 diabetes mellitus. Int J Clin Pract Suppl. 2000(113):54-62. Epub 2002/04/23. PubMed PMID: 11965833.
25. Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord. 2003;27(2):147-61. Epub 2003/02/15. doi: 10.1038/sj.ijo.802223. PubMed PMID: 12586994.
26. Ryu S, Kim DS, Lee MW, Lee JW, Sung KW, Koo HH, Yoo KH. Anti-leukemic effects of PPARgamma ligands. Cancer Lett. 2018;418:10-9. Epub 2018/01/15. doi: 10.1016/j.canlet.2018.01.020. PubMed PMID: 29331412.
27. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992;358(6389):771-4. Epub 1992/08/27. doi: 10.1038/358771a0. PubMed PMID: 1324435; PubMed Central PMCID: PMCPMC6159883.
28. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. Embo j. 1993;12(8):3171-82. Epub 1993/08/01. PubMed PMID: 8393784; PubMed Central PMCID: PMCPMC413583.